SCHEMBL10360404

SCHEMBL10360404

COC(=O)CN(CC(=O)OC)c1ccccc1OCCOc1cc(C(=O)OCc2ccccc2)c(C(C)=O)cc1N(CC(=O)OC)CC(=O)OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.50
L3MBTL1 Q9Y468 3/20 0.40
POLB P06746 2/20 0.40
MAPT P10636 2/20 0.40
KDM4E B2RXH2 3/20 0.40
LMNA P02545 2/20 0.40
RAB9A P51151 3/20 0.38
GAA P10253 1/20 0.38
STAT1 P42224 1/20 0.38
ALDH1A1 P00352 4/20 0.38
TSHR P16473 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP3A4 P08684 1/20 0.38
MAPK1 P28482 1/20 0.38
CASP3 P42574 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14033171 0.96 TDP1 (0.51) TDP1L3MBTL1POLBKDM4ELMNA
SCHEMBL10378725 0.82 TDP1 (0.57) TDP1MAPTKDM4ELMNARAB9A
SCHEMBL10378810 0.82 TDP1 (0.51) TDP1L3MBTL1POLBMAPTKDM4E
SCHEMBL30069487 0.77 TDP1 (0.69) TDP1L3MBTL1MAPTKDM4ELMNA
SCHEMBL9046522 0.75 ALDH1A1 (0.52) TDP1RAB9AALDH1A1SMN1; SMN2
SCHEMBL14654334 0.74 TDP1 (0.59) TDP1L3MBTL1MAPTKDM4EALDH1A1
SCHEMBL13435255 0.74 TDP1 (0.64) TDP1L3MBTL1POLBKDM4ELMNA
SCHEMBL14654314 0.73 TDP1 (0.57) TDP1L3MBTL1POLBMAPTKDM4E
SCHEMBL9378271 0.73 ALDH1A1 (0.45) TDP1KDM4ERAB9AALDH1A1MEN1
SCHEMBL16855860 0.72 TDP1 (0.56) TDP1L3MBTL1MAPTKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9097730-B2 Fluorescein lactone ion indicators and their applications AAT BIOQUEST, INC. (US) 2015-08-04 US disclosed
US-8927224-B2 Fluorescent ion indicators and their applications AAT BIOQUEST, INC. (US) 2015-01-06 US disclosed
US-8779165-B2 Fluorescent ion indicators and their applications AAT BIOQUEST, INC. (US) 2014-07-15 US disclosed
US-20140080170-A1 FLUORESCENT ION INDICATORS AND THEIR APPLICATIONS AAT BIOQUEST, INC. (US) 2014-03-20 US disclosed
US-20120183986-A1 Fluorescent lactone ion indicators and their applications AAT BIOQUEST, INC. 2012-07-19 US disclosed
US-20110229924-A1 Fluorescent ion indicators and their applications ABD BIOQUEST, INC. 2011-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110229924-A1 Fluorescent ion indicators and their applications SLC8B1, SLCO4C1, SLCO1A2 TDP1 3602/4885L3MBTL1 3581/4885POLB 3981/4885
US-20120183986-A1 Fluorescent lactone ion indicators and their applications CALR, FLI1, ECI1 TDP1 4702/4885L3MBTL1 2465/4885POLB 4625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.